Assessment of hypoxia in the stroma of patient-derived pancreatic tumor xenografts.

The primary patient-derived xenografts used for this study displayed a wide range of tumor hypoxia (1%–39%) that was highly significant ( p < 0.0001), whereas there was relatively little variance in the levels of hypoxia within replicates from the same model ( Figure 1 A).

also in 132,142 other papers